School of Medicine
Showing 301-350 of 485 Results
-
Amalia Perna
Postdoctoral Scholar, Pathology
BioDr. Perna received her education at the University of Urbino (BSc in Biological Science) and at the University of Trieste (MSc in Functional Genomics).
She obtained her Ph.D. in Neuroscience/Medical Sciences in 2021, from the University of Fribourg (Switzerland) in collaboration with the Swiss Integrative Center for Human Health (SICHH). During her doctoral studies, she investigated the molecular players involved in the neurodegenerative process, with special attention to Notch signaling modulation in the neuronal demise after kainic acid (KA)-induced excitotoxicity
With funding from the Swiss National Science Foundation (SNSF), Dr. Perna joined Prof. Thomas Montine's lab at Stanford University and extended her doctoral research work to single-cell technologies such as single-nucleus RNA-seq. In February 2022 she was appointed as a postdoctoral fellow in Montine Lab.
Dr. Perna’s research aims to elucidate the modulation of signaling pathways in the different cell types of the brain after the perturbation of its homeostasis. She is also interested in understanding the molecular mechanisms underlying neuronal regeneration/recovery after damage and in neurodegenerative diseases. -
Tho Duc Pham
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy areas of interest involve exploring antibody function as it relates to transfusion medicine, blood safety, and emerging infectious diseases. This ranges from natural immune responses to the ABO blood group, antibody profiling anti-SARS-CoV-2 antibodies, and studying HEV seroprevalence in the local community. I am also interested in exploring statistical approaches to improve blood product availability and overall health care efficiency in a tertiary care system.
-
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Jonathan Pollack
Professor of Pathology
Current Research and Scholarly InterestsResearch in the Pollack lab centers on translational genomics, with a focus on human cancer. The lab employs next-generation sequencing, single-cell genomics, genome editing, and cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include diseases of the prostate (prostate cancer and benign prostatic hyperplasia), as well as odontogenic neoplasms.
-
Mobeen Rahman
Clinical Assistant Professor, Pathology
BioI have interest in head and neck oncological surgical pathology. Specifically in salivary gland, thyroid, and skull base related malignancies.
Prior to joining faculty as an assistant professor at Stanford University, I completed a head and neck surgical pathology fellowship at the MD Anderson Cancer Center (2019). Following this subspecialty fellowship, I was faculty as a head and neck only pathologist at Cleveland Clinic for three years. -
Donald Regula, MD
Professor (Teaching) of Pathology and, by courtesy, of Orthopaedic Surgery
BioDr. Regula was the course director for the required medical student course, Science of Medicine, and previously the course director of the required pathology course (1993-2020)
He was the Director of the Stanford Autopsy Service (1995-2021)
He is the faculty co-lead for the EPIC Beaker-AP implementation project. -
Pema Richeson
Research Program Manager, Pathology - Montine Lab
Current Role at StanfordProgram Manager | Team eDyNAmiC, Cancer Grand Challenges
Project Manager | PPMI Pathology Core
Center Administrator | Stanford SeroNet Center of Excellence -
Kerri E. Rieger, MD, PhD
Clinical Professor, Pathology
Clinical Professor, DermatologyBioDr. Rieger is a Clinical Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in cutaneous lymphoma, hospitalized patients, and patients with autoimmune disease. She also sees patients in the Stanford dermatology clinic in Portola Valley, where her clinical interest is adult general dermatology.
-
Suman Rimal
Postdoctoral Scholar, Pathology
BioResearch interests: Genetic mechanism underlying mitochondrial pathology, neurodegeneration, and muscle loss using Drosophila as a model organism.
-
Theodore Roth
Affiliate, Dean's Office Operations - Dean Other
Resident in PathologyCurrent Research and Scholarly InterestsScalable technologies for engineering next generation cellular therapies
-
Atif Saleem
Clinical Assistant Professor (Affiliated), Pathology Clinical
Staff, Pathology Operations supported expensesBioDr. Atif Saleem completed his residency training in Anatomic and Clinical Pathology, followed by fellowships in Hematopathology and Dermatopathology at Stanford. He is board certified in both Anatomic Pathology and Clinical Pathology, Hematopathology, and Dermatopathology. His interests include virus-associated neoplasms, medical education, and global health.
-
Darren Salmi
Clinical Assistant Professor, Pathology
Current Research and Scholarly InterestsCardiovascular pathology, congenital heart disease, autopsy, medical education
-
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Shamloo’s lab in March 2021 focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK) working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012 Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy) during which he undertook an internship at the King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
